Accord Logo

Intended for UK patients and members of the public

SmPC - Naveruclif® 5 mg/ml powder for dispersion for infusion: Change history

Back to products
  • View Summary of Product Characteristics (SmPC - Naveruclif® 5 mg/ml powder for dispersion for infusion)

    Last updated on this site: 19 Dec 2025

    New product launch

    Launch date: 18/12/25

    View change history

    • Changes: (Updated: 19 Dec 2025)

      New product launch

      Launch date: 18/12/25

    Back to Top

    View product information as a: